Toll-like receptor 4 polymorphisms and aspergillosis.
Levitz
Stuart M
SM
Shoham
Shmuel
S
Cleary
John D
JD
D000666:Amphotericin B / Q000276:immunology* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000276:immunology* / Q000627:therapeutic use; D001228:Aspergillosis / Q000235:genetics*; D001232:Aspergillus fumigatus; D020022:Genetic Predisposition to Disease; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D009503:Neutropenia / Q000188:drug therapy; D051195:Toll-Like Receptor 2 / Q000276:immunology; D051197:Toll-Like Receptor 4 / Q000235:genetics* / Q000276:immunology
D000935:Antifungal Agents; C495342:TLR2 protein, human; C495345:TLR4 protein, human; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4; D000666:Amphotericin B